Skip to Content
Print Save

J63 (Morphine Sulfate Extended-Release 30 mg)

Pill with imprint J63 is Purple, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 30 mg. It is supplied by Amneal Pharmaceuticals LLC.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for J63

Morphine sulfate extended-release 30 mg J63
Morphine sulfate extended-release 30 mg J63
Morphine sulfate extended-release 30 mg J63

Morphine Sulfate Extended-Release

Imprint
J63
Strength
30 mg
Color
Purple
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
00115-1278
Inactive Ingredients
hypromelloses, ethylcelluloses, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, diethyl phthalate, magnesium silicate, corn starch, sucrose, FD&C Blue No. 1, FD&C Red No. 3, gelatin, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "J63"

Tydemy
Symtuza

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer